Retraction Note: Cancer Cell International (2021) 21:186
The Editors in Chief have retracted this article. After publication, concerns were raised about multiple images that appear to overlap with previously-published works, namely:
Figure 6a overlaps with Figure 9C from [1].
Figure 6a overlaps with Figure 2I from [2].
Figure 6a overlaps with Figure 8A from [3].
Figure 5c and d overlap with Figure 1R from [4].
Figure 6c overlaps with Figure 5G from [5].
Figures 3g and 4g overlap with Figures 4L, 4M, 6L and 6M from [6].
Supplementary Figure S2A overlaps with Figure 4C from [7].
Supplementary Figure S2A overlaps with Figure 5A from [8].
The authors have stated that they had used third-party services that provided them with data, Therefore, the Editors in Chief have lost confidence in the findings of this paper. All authors agree to this retraction.
References
Zheng X, Huang M, Xing L, et al. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer. Mol Cancer. 2020;19:73. https://doi.org/10.1186/s12943-020-01183-9.
Ding J, Wang X, Gao J, Song T. Silencing of cystatin SN abrogates cancer progression and stem cell properties in papillary thyroid carcinoma. FEBS Open Bio. 2021;11:2186–97. https://doi.org/10.1002/2211-5463.13221.
Li X, Wang H, Liu Z, Abudureyimu A. CircSETD3 (Hsa_circ_0000567) suppresses Hepatoblastoma Pathogenesis via targeting the miR-423-3p/Bcl-2-Interacting mediator of Cell Death Axis. Front Genet. 2021;12:724197. https://doi.org/10.3389/fgene.2021.724197.
Huang W, Shi G, Yong Z, et al. Downregulation of RKIP promotes radioresistance of nasopharyngeal carcinoma by activating NRF2/NQO1 axis via downregulating miR-450b-5p. Cell Death Dis. 2020;11:504. https://doi.org/10.1038/s41419-020-2695-6.
Zhu X, Han J, Lan H, et al. A novel circular RNA hsa_circRNA_103809/miR-377-3p/GOT1 pathway regulates cisplatin-resistance in non-small cell lung cancer (NSCLC). BMC Cancer. 2020;20:1190. https://doi.org/10.1186/s12885-020-07680-w.
Li C, Qiu J, Xue Y. Low-dose Diosbulbin-B (DB) activates tumor-intrinsic PD-L1/NLRP3 signaling pathway mediated pyroptotic cell death to increase cisplatin-sensitivity in gastric cancer (GC). Cell Biosci. 2021;11:38. https://doi.org/10.1186/s13578-021-00548-x.
Yu L, Shi Q, Jin Y, et al. Blockage of AMPK-ULK1 pathway mediated autophagy promotes cell apoptosis to increase doxorubicin sensitivity in breast cancer (BC) cells: an in vitro study. BMC Cancer. 2021;21:195. https://doi.org/10.1186/s12885-021-07901-w.
Zheng Y, Liu L, Wang Y, et al. Glioblastoma stem cell (GSC)-derived PD-L1-containing exosomes activates AMPK/ULK1 pathway mediated autophagy to increase temozolomide-resistance in glioblastoma. Cell Biosci. 2021;11:63. https://doi.org/10.1186/s13578-021-00575-8.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
The online version of the original article can be found at https://doi.org/10.1186/s12935-021-01885-0.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Du, J., Zhong, H. & Ma, B. Retraction Note: Targeting a novel LncRNA SNHG15/miR-451/c-Myc signaling cascade is effective to hamper the pathogenesis of breast cancer (BC) in vitro and in vivo. Cancer Cell Int 23, 201 (2023). https://doi.org/10.1186/s12935-023-03049-8
Accepted:
Published:
DOI: https://doi.org/10.1186/s12935-023-03049-8